EZZ Life Science Holdings Limited (ASX:EZZ)

EZZ Life Science Holdings Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	86	110	82	21	13	19
Market Cap Growth	-24.69%	34.71%	283.76%	61.08%	-29.08%	-
Enterprise Value	65	91	70	12	4	15
Last Close Price	1.83	2.32	1.80	0.47	0.28	0.40
PE Ratio	12.61	16.40	11.77	5.88	10.10	9.20
Forward PE	-	12.38	7.87	-	-	-
PS Ratio	1.29	1.65	1.23	0.57	0.88	0.84
PB Ratio	3.07	3.93	3.84	1.46	1.16	1.85
P/TBV Ratio	3.08	3.93	3.85	1.47	1.17	1.85
P/FCF Ratio	20.92	26.76	14.29	5.46	6.99	75.50
P/OCF Ratio	19.75	25.26	13.34	5.32	6.97	73.72
EV/Sales Ratio	0.97	1.36	1.05	0.32	0.29	0.67
EV/EBITDA Ratio	6.21	9.02	7.14	2.55	2.41	5.43
EV/EBIT Ratio	6.53	9.16	7.17	2.56	2.43	5.46
EV/FCF Ratio	15.73	22.05	12.14	3.02	2.29	60.63
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.01	0.01
Debt / EBITDA Ratio	0.03	0.03	0.01	0.10	0.05	0.03
Debt / FCF Ratio	0.07	0.07	0.02	0.12	0.06	0.32
Asset Turnover	2.25	2.25	3.08	2.33	1.14	2.45
Inventory Turnover	8.95	8.95	13.79	14.86	25.73	64.57
Quick Ratio	4.59	4.59	5.33	5.43	4.53	5.72
Current Ratio	5.77	5.77	5.96	5.80	4.96	6.08
Return on Equity (ROE)	27.24%	27.24%	38.79%	27.95%	12.21%	32.44%
Return on Assets (ROA)	20.86%	20.86%	28.12%	18.08%	8.48%	18.85%
Return on Invested Capital (ROIC)	94.96%	148.27%	573.17%	446.69%	111.46%	679.45%
Return on Capital Employed (ROCE)	35.20%	35.20%	45.50%	31.40%	15.60%	27.20%
Earnings Yield	7.80%	6.10%	8.50%	17.00%	9.90%	10.87%
FCF Yield	4.78%	3.74%	7.00%	18.32%	14.30%	1.32%
Dividend Yield	2.18%	-	1.95%	4.20%	1.59%	1.12%
Payout Ratio	27.00%	27.00%	15.53%	16.54%	13.20%	-
Buyback Yield / Dilution	-7.35%	-7.35%	-0.89%	-0.46%	-25.23%	-13.15%
Total Shareholder Return	-5.16%	-7.35%	1.06%	3.74%	-23.64%	-12.03%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.